USP32 and cholangiocarcinoma: In terms of statistical significance, six of them, including cholangiocarcinoma (CHOL), esophageal carcinoma (ESCA), head and neck squamous cell carcinoma (HNSC), hepatocellular carcinoma (LIHC), and stomach adenocarcinoma (STAD), displayed increased levels of USP32 mRNA expression.